Katalin Márta

ORCID: 0000-0002-2213-4865
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatitis Pathology and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Liver Disease Diagnosis and Treatment
  • Gastrointestinal disorders and treatments
  • Pediatric Hepatobiliary Diseases and Treatments
  • Appendicitis Diagnosis and Management
  • Gallbladder and Bile Duct Disorders
  • COVID-19 Clinical Research Studies
  • Childhood Cancer Survivors' Quality of Life
  • Esophageal and GI Pathology
  • Celiac Disease Research and Management
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Gastroesophageal reflux and treatments
  • Hormonal Regulation and Hypertension
  • Adrenal Hormones and Disorders
  • Eosinophilic Esophagitis
  • Microscopic Colitis
  • Helicobacter pylori-related gastroenterology studies
  • Healthcare cost, quality, practices
  • Lymphatic Disorders and Treatments
  • Cancer survivorship and care
  • Abdominal vascular conditions and treatments
  • Inflammatory Bowel Disease
  • Renal function and acid-base balance
  • Adolescent and Pediatric Healthcare

Semmelweis University
2017-2024

University of Pecs
2016-2024

Vilnius University Hospital Santariskiu Klinikos
2020

Fejér Megyei Szent György Egyetemi Oktató Kórház
2018

Heim Pál Gyermekkórház
2017

Hungarian Academy of Sciences
2017

University of Szeged
2016-2017

Center for Translational Molecular Medicine
2017

Hypertriglyceridemia is the third most common cause of acute pancreatitis (AP). It has been shown that hypertriglyceridemia aggravates severity and related complications AP; however, detailed analyses large cohorts are contradictory. Our aim was to investigate dose-dependent effect on AP. AP patients over 18 years old who underwent triglyceride measurement within initial three days were included into our cohort analysis from a prospective international, multicenter registry operated by...

10.1016/j.pan.2020.03.018 article EN cc-by Pancreatology 2020-04-10
Andrea Párniczky Tamás Lantos Eszter Tóth Zsolt Szakács Szilárd Gódi and 95 more Roland Hágendorn Dóra Illés Balázs Koncz Katalin Márta Alexandra Mikó Dóra Mosztbacher Balázs Csaba Németh Dániel Pécsi Anikó Szabó Ákos Szücs Péter Varjú Andrea Szentesi Erika Darvasi Bálint Erőss Ferenc Izbéki László Gajdán Adrienn Halász Áron Vincze Imre Szabó Gabriella Pár Judit Bajor Patrícia Sarlós József Czimmer József Hamvas Tamás Takács Zoltán Szepes László Czakó Márta Varga János Novák Barnabás Bod Attila Szepes János Sümegi Mária Papp Csaba Góg Imola Török Wei Huang Qing Xia Ping Xue Weiqin Li Weiwei Chen N. V. Shirinskaya В. Л. Полуэктов Anna V. Shirinskaya Péter Hegyi M Bátovský Juan A. Rodríguez-Oballe Isabel Miguel Salas Javier López J. Enrique Domínguez‐Muñoz Xavier Molero Elizabeth Pando María Lourdes Ruiz-Rebollo Beatriz Burgueño-Gómez Yu‐Ting Chang Ming-Chu Chang Ajay Sud Danielle Moore Robert Sutton Amir Gougol Georgios I. Papachristou Y. M. Susak Illia Olehovych Tiuliukin António Gomes Maria Jesus Oliveira David Aparício Marcel Tanțău Floreta Kurti Mila Kovacheva-Slavova Stephanie-Susanne Stecher Julia Mayerle Goran Poropat Kshaunish Das Marco V. Marino Gabriele Capurso Ewa Małecka‐Panas Hubert Zatorski Anita Gąsiorowska Natalia Fabisiak Piotr Ceranowicz Beata Kuśnierz‐Cabala Joana Rita Carvalho Samuel Fernandes Jae Hyuck Chang Eun Kwang Choi Jimin Han Sara Bertilsson Hanaz Jumaa Gabriel Sandblom Sabite Kaçar Minas Baltatzis Aliaksandr Varabei Vizhynis Yeshy S. Chooklin A. Kozachenko Nikolay Veligotsky

10.1016/j.pan.2019.04.003 article EN Pancreatology 2019-04-19

The in-hospital survival of patients suffering from acute pancreatitis (AP) is 95% to 98%. However, there growing evidence that discharged after AP may be at risk serious morbidity and mortality. Here, we aimed investigate the risk, causes, predictors most severe consequence post-AP period: mortality.A total 2613 well-characterized 25 centers were included followed by Hungarian Pancreatic Study Group between 2012 2021. A general a hospital-based population was used as control group.After an...

10.1053/j.gastro.2023.05.028 article EN cc-by Gastroenterology 2023-05-27

The incidence of acute pancreatitis (AP) and the prevalence metabolic syndrome (MetS) are growing worldwide. Several studies have confirmed that obesity (OB), hyperlipidemia (HL), or diabetes mellitus (DM) can increase severity, mortality, complications in AP. However, there is no comprehensive information on independent joint effect MetS components outcome Our aims were (1) to understand whether an AP (2) examine their combinations.From 2012 2017, 1435 cases from 28 centers included...

10.3389/fphys.2019.01202 article EN cc-by Frontiers in Physiology 2019-09-20

Introduction: Our meta-analysis indicated that aging influences the outcomes of acute pancreatitis (AP), however, a potential role for comorbidities was implicated, as well. Here we aimed to determine how age and modify in AP cohort-analysis Hungarian cases. Materials methods: Data patients diagnosed with by revised Atlanta criteria were extracted from Registry Pancreatic Patients. Outcomes interest mortality, severity, length hospitalization, local, systemic complications AP. Comorbidities...

10.3389/fphys.2018.01776 article EN cc-by Frontiers in Physiology 2019-04-02

Objective This study aimed to develop and validate a patient-reported outcome measure (PROM) in acute pancreatitis (AP) as an endpoint centred on the patient. Design A PROM instrument (PAtieNt-rePoRted OutcoMe scale pancreatItis, international proSpEctive cohort study, PAN-PROMISE scale) was designed based opinion of patients, professionals expert panel. The validated multicentre prospective describing severity AP quality life at 15 days after discharge main variables for validation. COSMIN...

10.1136/gutjnl-2020-320729 article EN Gut 2020-04-03

Abstract Chronic pancreatitis (CP) is an end-stage disease with no specific therapy; therefore, early diagnosis of crucial importance. In this study, data from 1315 and 318 patients were analysed acute (AP) CP registries, respectively. The population the AP registry was divided into (n = 983), recurrent (RAP, n 270) 62) groups. prevalence in combination AP, RAP2, RAP3, RAP4 RAP5 + 0%, 1%, 16%, 50% 47%, respectively, suggesting that three or more episodes a strong risk factor for CP....

10.1038/s41598-020-80532-6 article EN cc-by Scientific Reports 2021-01-14

Abstract Introduction Non‐alcoholic fatty liver disease (NAFLD) is a proven risk factor for acute pancreatitis (AP). However, NAFLD has recently been redefined as metabolic‐associated (MAFLD). In this post hoc analysis, we quantified the effect of MAFLD on outcomes AP. Methods We identified our patients from multicentric, prospective International Acute Pancreatitis Registry Hungarian Pancreatic Study Group. Next, compared AP with and without individual components regarding in‐hospital...

10.1002/ueg2.12389 article EN cc-by-nc-nd United European Gastroenterology Journal 2023-04-16

Abstract Pancreatic necrosis is a consistent prognostic factor in acute pancreatitis (AP). However, the clinical scores currently use are either too complicated or require data that unavailable on admission lack sufficient predictive value. We therefore aimed to develop tool aid prediction. The XGBoost machine learning algorithm processed from 2387 patients with AP. confidence of model was estimated by bootstrapping method and interpreted via 10th 90th percentiles prediction scores. Shapley...

10.1038/s41598-022-11517-w article EN cc-by Scientific Reports 2022-05-12

Introduction Acute pancreatitis (AP) is an inflammatory disease with no specific treatment. Mitochondrial injury followed by ATP depletion in both acinar and ductal cells a recently discovered early event its pathogenesis. Importantly, preclinical research has shown that intracellular delivery restores the physiological function of protects from cell injury, suggesting restoration energy levels pancreas therapeutically beneficial. Despite several high quality experimental observations this...

10.1136/bmjopen-2017-015874 article EN cc-by-nc BMJ Open 2017-09-01

Background C-reactive protein level (CRP) and white blood cell count (WBC) have been variably used in clinical trials on acute pancreatitis (AP). We assessed their potential role. Methods First, we investigated studies which CRP or WBC, to describe current role AP. Second, extracted the data of 1435 episodes AP from our registry. WBC admission, within 24 hours onset pain highest values were analyzed. Descriptive statistical tools as Kruskal-Wallis, Mann-Whitney U, Levene's F tests, Receiver...

10.3389/fphys.2019.01092 article EN cc-by Frontiers in Physiology 2019-09-04
Coming Soon ...